Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Tonix Pharmaceuticals Holding (TNXP) EBT Margin: 2023-2025

Historic EBT Margin for Tonix Pharmaceuticals Holding (TNXP) over the last 2 years, with Sep 2025 value amounting to -967.66%.

  • Tonix Pharmaceuticals Holding's EBT Margin fell 40646.00% to -967.66% in Q3 2025 from the same period last year, while for Sep 2025 it was -951.92%, marking a year-over-year increase of 30416.00%. This contributed to the annual value of -1,354.28% for FY2024, which is 9007.00% down from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported EBT Margin of -967.66% as of Q3 2025, which was up 30.12% from -1,384.78% recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's EBT Margin registered a high of -561.20% during Q3 2024, and its lowest value of -3,501.54% during Q2 2024.
  • Moreover, its 3-year median value for EBT Margin was -860.23% (2024), whereas its average is -1,136.81%.
  • Data for Tonix Pharmaceuticals Holding's EBT Margin shows a peak YoY increase of 211,676bps (in 2025) and a maximum YoY decrease of 40,646bps (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Tonix Pharmaceuticals Holding's EBT Margin stood at -723.00% in 2023, then tumbled by 14,765bps to -870.64% in 2024, then slumped by 40,646bps to -967.66% in 2025.
  • Its last three reported values are -967.66% in Q3 2025, -1,384.78% for Q2 2025, and -660.93% during Q1 2025.